Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis-Reference-Cited by-同舟云学术

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

Published:2001-11 Issue:11 Volume:29 Page:2051-2059
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Bernard Gordon R.,Ely E. Wesley,Wright Theressa J.,Fraiz Joseph,Stasek Jerome E.,Russell James A.,Mayers Irvin,Rosenfeld Brian A.,Morris Peter E.,Yan S. Betty,Helterbrand Jeffery D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference59 articles.

1. The Mortality of Hospital-Acquired Bloodstream Infections: Need for a New Vital Statistic?

2. Treating Patients with Severe Sepsis

3. The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)

4. AGE-SPECIFIC INCIDENCE AND OUTCOME OF SEPSIS IN THE US

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Anticoagulant Therapy in Patients with Sepsis: A Meta-Analysis of Randomized Controlled Trials;2024

2. The Unexpected Protective Role of Thrombosis in Sepsis-Induced Inflammatory Lung Injury Via Endothelial Alox15;2023-03-31

3. Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation;Acute Medicine & Surgery;2023-01

4. Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH;Frontiers in Immunology;2022-09-12

5. DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT;Shock;2022-09-06